Mitchell C. Posner to Antibodies, Anti-Idiotypic
This is a "connection" page, showing publications Mitchell C. Posner has written about Antibodies, Anti-Idiotypic.
Connection Strength
0.076
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.076